Looks like you’re on the US site. Choose another location to see content specific to your location
Johnson & Johnson announced the release of Velys Spine, a stand-alone navigation platform and surgical robot. J&J and eCential Robotics developed a 510(k)-cleared device that is intended to guide screw insertion during both freehand and robotically assisted spine surgery.
In the first half of 2025, J&J’s Depuy Synthes intends to commercialise the technology. The technology will be added to the other Velys products that J&J has identified as helping to boost its knee and hip businesses.
In Q2, the company’s knee sales surged by 8.4% to $394 million, while its hip sales climbed by about 5% over the previous year to $417 million.
In June, J&J received 510(k) authorisation for the use of its Velys surgical robot in partial knee replacement surgeries. The robot is a component of J&J’s strategy, which also includes concentrating on ambulatory surgical centres, to wrest market share away from Stryker and Zimmer Biomet.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard